Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-3.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Cash from Investing Activities (2023 - 2026)

Updated

Mereo BioPharma (MREO) recorded Cash from Investing Activities of -$300,000 in Q1 2026, compared with -$320,000 a year earlier.

Analysis

Mereo BioPharma (MREO) Cash from Investing Activities (2023 - 2026) Analysis & Trends

For FY2025, Mereo BioPharma reported Cash from Investing Activities of -$20,000.

  • Across earlier years, Cash from Investing Activities came in at -$699,000 in FY2024, -$419,000 in FY2023, $1.99 million in FY2022 and -$567,512 in FY2021.
  • Quarterly Cash from Investing Activities has ranged from -$700,000 in Q1 2024 to $300,000 in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 Mereo BioPharma 44.71 Mn -105.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -300,000.00
Sep 30, 2025 300,000.00
Mar 31, 2025 -320,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 -700,000.00
Mar 31, 2023 -419,000.00
API Access

Mereo BioPharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=MREO&period=max&api_key=YOUR_API_KEY